Get 20% Off All Market Studies With Code ONLINE20 – Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends
What Is the Peptide Therapeutics Market Growth Potential Across Different Regions?
The peptide therapeutics market size has grown strongly in recent years. It will grow from $45.15 billion in 2024 to $49.21 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing incidence of chronic diseases, growing understanding of molecular biology, expanding applications in oncology.
The peptide therapeutics market size is expected to see rapid growth in the next few years. It will grow to $74.98 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to rising demand for personalized medicine, expanding use in immunotherapy, advancements in peptide delivery systems, emerging peptide targets in infectious diseases, increasing focus on rare diseases. Major trends in the forecast period include technological advancements in peptide synthesis, growing investment and funding, emphasis on peptide drug safety, market expansion in emerging economies, integration of artificial intelligence (AI).
Claim your free report sample now:
What Are the Critical Growth Contributors in the Peptide Therapeutics Market?
An increase in the prevalence of chronic diseases is expected to propel the growth of the peptide therapeutics market. Chronic diseases are long-lasting sickness that often cannot be healed, however, they are occasionally curable and controllable. Chronic diseases are increasing due to increased use of tobacco products, poor nutrition, physical inactivity, excessive alcohol use, and others. The use of peptide therapeutics aids in the prevention and treatment of certain chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition would increase by 99.5%, that is 142.66 million, by 2050. Therefore, the increase in the prevalence of chronic diseases is expected to drive the peptide therapeutics market during the forecast period.
Which Segments Are Attracting Maximum Investment in the Peptide Therapeutics Market?
The peptide therapeutics market covered in this report is segmented –
1) By Type: Generic, Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications
Subsegments:
1) By Generic: Generic Peptide Drugs, Biosimilars
2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides
What Are the Future Trends Forecasted for the Peptide Therapeutics Market?
Major companies operating in the peptide therapeutics market are focused on introducing advanced solutions, such as cell culture process, to gain a competitive edge in the market. Cell culture process is the process of growing cells outside of their natural environment, under controlled conditions which involves isolating cells of interest from living tissue and subsequently maintaining them. For instance, in June 2023, Evonik Industries AG, a German-based specialty chemicals company launched cQrex KC. cQrex KC is next-generation peptide for biopharma applications designed for cell culture process used in the manufacture of biological drugs. It enables cell culture process developers to optimize cystine supply and increase cell culture productivity. cQrex KC supports the development of vaccines, viral vectors, and cell therapies.
Which Are the Major Market Players in the Peptide Therapeutics Industry?
Major companies operating in the peptide therapeutics market include Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.
Get the full peptide therapeutics market report here:
Which Regions Are Forecasted to Experience the Fastest Growth in the Peptide Therapeutics Market?
North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment